Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 3 Carcinoma, Renal Cell 3 Prostatic Neoplasms 2 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Penile Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Vincristine 16 Cyclophosphamide 16 Filgrastim 13 Etoposide 12 Doxorubicin 12 Radiotherapy 11 Carboplatin 10 X-Rays 9 Dactinomycin 9 Specimen Handling 8 Phantoms, Imaging 8 Magnetic Resonance Spectroscopy 8 Granulocyte Colony-Stimulating Factor 8 Temozolomide 6 Melphalan 6 Ifosfamide 6 Topotecan 5 Polymerase Chain Reaction 5 Peripheral Blood Stem Cell Transplantation 5 Nuclear Medicine Department, Hospital 5 Irinotecan 5 Busulfan 5 Biopsy 5 sargramostim 4 Stem Cell Transplantation 4 Gene Expression Profiling 4 Amplified Fragment Length Polymorphism Analysis 4 Thiotepa 3 Reverse Transcriptase Polymerase Chain Reaction 3 Radiation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Wilms Tumor × Isotretinoin × Genitourinary × Clear all

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡